Acute Coronary Syndrome Market Research Reports

Acute Coronary Syndrome Market Research


Acute Coronary Syndrome covers the spectrum of clinical conditions ranging from unstable angina to ... view more

RSS Sort By :
TITLE Price Buy Now More options

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Coronary Syndrome – Pipeline Review, H2 2016, provides an overview of the Acute Coronary Syndrome (Cardiovascular) pipeline landscape.Acute coronary syndrome...

$ 2000


DelveInsight “Acute coronary syndrome (ACS) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Acute coronary syndrome (ACS) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 yea...

$ 2750


DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, ...

$ 4950


DelveInsight’s Report, “Acute Coronary Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across...

$ 2000


Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Acute Coronary Syndrom...

$ 2500


Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality in the world. The term acute coronary syndrome (ACS) applies to a spectrum of acute CVD states that are precipitated by coronary artery...

$ 10995


EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025 Summary Acute coronary syndrome (ACS) is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalization...

$ 3995


The Global Acute Coronary Syndrome Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Acute Coronary Syndrome industry. Firstly, the report provides a basic overview of the industry inc...

$ 2800


Global Markets Direct’s, ‘Acute Coronary Syndrome - Pipeline Review, H1 2016’, provides an overview of the Acute Coronary Syndrome pipeline landscape.The report provides comprehensive information on the therapeutics u...

$ 2000


Note*: This report requires 5-10 business days to complete. DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global m...

$ 4950


Global Markets Direct's, ?Acute Coronary Syndrome Pipeline Review, H2 2015', provides an overview of the Acute Coronary Syndrome's therapeutic pipeline.This report provides comprehensive information on the therapeutic developmen...

$ 2000


Global Markets Direct's, ?Acute Coronary Syndrome - Pipeline Review, H1 2015', provides an overview of the Acute Coronary Syndrome's therapeutic pipeline.This report provides comprehensive information on the therapeutic developm...

$ 2000


ACS is a condition that results in sudden and reduced blood flow to the heart. ACS is a serious cardiovascular disease associated with high healthcare costs, frequent recurrences and hospitalizations, and short-term mortality. On the basis of evid...

$ 2500


Global Markets Direct's, ?Acute Coronary Syndrome Pipeline Review, H2 2014', provides an overview of the Acute Coronary Syndrome's therapeutic pipeline.This report provides comprehensive information on the therapeutic developmen...

$ 2000


PharmaPoint: Acute Coronary Syndrome - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Acute Coronary Syndrome - Current and Future Players”. The report is a vital source of up-to-d...

$ 2995


GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug market will grow at a CAGR of 13.4% over the t...

$ 4995


GlobalData has released its new PharmaPoint Drug Evaluation report, “Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market – primarily comprised of antithrombotics, antihypertensives,...

$ 3495


GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug market will grow at a CAGR of 13.4% over the t...

$ 4995


GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug market will grow at a CAGR of 13.4% over the t...

$ 10995


GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded drug sales (40%) and $7.3bn in generic sales (60%). GlobalData expects that the ACS drug market will grow at a CAGR of 13.4% over the t...

$ 6995

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: